This is a multicentric observational study with a total duration of 3 years. The recruitment of participants is foreseen up to 18 first months of the project CITEMB, from November 2022 to April 2024. Positive cases will be followed up during the whole pregnancy and until delivery. Additionally, newborns with a positive CMV-PCR test will be followed up until 12 months of age. The study will be conducted in four primary care settings from the Northern Metropolitan Barcelona area, ASSIR (abbreviation for ASSIR in Catalan stands for primary attention centres of sexual and reproductive health) Muntanya, ASSIR Esquerra, ASSIR Santa Coloma de Gramenet, ASSIR Badalona-Sant Adrià, and three related hospitals, Hospital Universitari Vall d'Hebron, BCNatal Hospital Clinic/Hospital Universitari Sant Joan de Deu and Hospital Universitari Trias i Pujol.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.